Literature DB >> 2784840

Regulation of uterine epidermal growth factor (EGF) receptors by estrogen in the mature rat and during the estrous cycle.

R M Gardner1, G Verner, J L Kirkland, G M Stancel.   

Abstract

Previous work has shown that the immature rat uterus contains epidermal growth factor (EGF) receptors and that tissue levels of this receptor are increased by the administration of exogenous estrogens. This study was undertaken to determine if estrogen administration also elevated EGF receptor levels in the mature animal and if the growth factor receptor levels varied in concert with endogenous estrogens throughout the estrous cycle. In the mature, castrate rat administration of estradiol, but not non-estrogenic steroids, causes a 2-3-fold elevation of uterine EGF receptors as judged by ligand binding. This increase is maximum in 18 h and is due to an increase in the number of binding sites. In cycling animals EGF receptor levels are low at metestrus, rise at diestrus, reach a maximum (approximately twice metestrus values) at proestrus, and then return at estrus to metestrus levels. These changes in EGF receptor levels parallel changes in plasma estrogens and occupied nuclear estrogen receptor reported by other workers. These results indicate that uterine EGF receptors are increased by exogenous estrogens in both mature and immature animals, and support a physiological role for estrogens in the regulation of this growth factor receptor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784840     DOI: 10.1016/0022-4731(89)90205-7

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  9 in total

1.  Gene expression of transforming growth factor-alpha in human endometrium during decidualization.

Authors:  M Taga; H Sakakibara; K Suyama; M Ikeda; H Minaguchi
Journal:  J Assist Reprod Genet       Date:  1997-04       Impact factor: 3.412

2.  Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor.

Authors:  S W Curtis; T Washburn; C Sewall; R DiAugustine; J Lindzey; J F Couse; K S Korach
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

3.  Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor.

Authors:  D M Ignar-Trowbridge; K G Nelson; M C Bidwell; S W Curtis; T F Washburn; J A McLachlan; K S Korach
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

4.  The profile of the epidermal growth factor system in rat endometrium during postpartum involution period.

Authors:  Emel Alan; Narin Liman; Hakan Sağsöz
Journal:  Vet Res Commun       Date:  2015-03-11       Impact factor: 2.459

Review 5.  Antiestrogen action and growth factor regulation.

Authors:  L C Murphy
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

6.  Epidermal growth factor receptor and c-erbB-2 expression in normal breast tissue during the menstrual cycle.

Authors:  A Gompel; A Martin; P Simon; D Schoevaert; G Plu-Bureau; D Hugol; J Audouin; E Leygue; J B Truc; P Poitout
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 7.  Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways.

Authors:  Emily M Fox; Josefa Andrade; Margaret A Shupnik
Journal:  Steroids       Date:  2008-11-05       Impact factor: 2.668

8.  Developmental exposure to diethylstilbestrol alters uterine gene expression that may be associated with uterine neoplasia later in life.

Authors:  Retha R Newbold; Wendy N Jefferson; Sherry F Grissom; Elizabeth Padilla-Banks; Ryan J Snyder; Edward K Lobenhofer
Journal:  Mol Carcinog       Date:  2007-09       Impact factor: 4.784

Review 9.  Cross talk between peptide growth factor and estrogen receptor signaling systems.

Authors:  D M Ignar-Trowbridge; M Pimentel; C T Teng; K S Korach; J A McLachlan
Journal:  Environ Health Perspect       Date:  1995-10       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.